About this trial
To assess mortality and morbidity associated to anesthesia interventions
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All individuals
Individuals agreeing to participate in the study by signing a consent
Disqualifiers
The subjects who had insufficient data in their files
Trial population
Individuals of all ages being admitted at Clinica Alemana de Santiago that will require or were in care by an anesthesiologist.
Trial design
Cohort
Other
Treatments tested in this trial
Anesthesia Intervention
Procedure/SurgeryPatients exposed to any anesthesia intervention will be assessed to whether the exposure to anesthesia confers a risk for perioperative outcomes
Treatment groups
Trial outcomes
Primary outcomes
All-cause mortality rate in the postoperative period
Posoperative mortality of individuals exposed to any anesthesia related intervention or event
All-cause mortality rate in the posoperative period
Posoperative mortality of individuals exposed to any anesthesia related intervention or event
Number of patients presenting a complication in the posoperative period
Perioperative morbidity of individuals exposed to any anesthesia related intervention or event.
Number of patients who needed rehospitalization in the posoperative period
Posoperative rehospitalization rate of individuals exposed to any anesthesia related intervention or event, after primary discharge
Secondary outcomes
Change from baseline in pain, as measured by the visual analog scale (VAS)
Scores are measured on a 10-point VAS. The VAS ranges from 0 to 10 with 0 indicating no pain, and higher scores indicating greater pain.
Number of patients that develops postoperative acute kidney injury, as measured by Kidney Disease Improving Global Outcomes (KIDGO)-2012 serum creatinine criteria
Criteria for developing acute kidney injury are: Increase in serum creatinin by ≽0.3 mg/dl (≽26.5lmol/l) within 48hours; or Increase in serum creatinine ≽1.5 times baseline, which is known or presumed to have occurred within the prior 7 days; or Urine volume \< 0.5ml/kg/h for 6hours.
Number of patients that develops postoperative Major Acute Cardiac Events (MACE), as defined by the American Heart Association
Criteria for MACE are the development of any of the following conditions Non-fatal stroke Non-fatal myocardial infarction Cardiovascular death
Number of patients that develop posoperative chronic pain as measured by visual analog scale
Scores are measured on a 10-point VAS. The VAS ranges from 0 to 10 with 0 indicating no pain, and higher scores indicating greater pain.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: